Source author record

Maximilian Linde

Maximilian Linde appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
3topics
3close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2026arXiv

Who and What? Using Linguistic Features and Annotator Characteristics to Analyze Annotation Variation

Human label variation has been established as a central phenomenon in NLP: the perspectives different annotators have on the same item need to be embraced. Data collection practices thus shifted towards increasing the annotator numbers and releasing disaggregated datasets, harmful language being most resourced due to its high subjectivity. While this resulted in rich information about \textit{who} annotated (sociodemographics, attitudes, etc.), the \textit{what} (e.g., linguistic properties of items), and their interplay has received little attention. We present the first large-scale analysis of four reference datasets for harmful language detection, bringing together annotator characteristics, linguistic properties of the items, and their interactions in a statistically informed picture. We find that interactions are crucial, revealing intersectional effects ignored in previous work, and that a strong role is played by lexical cues and annotator attitudes. Effect patterns, however, vary considerably across datasets. This urges caution about generalization and transferability.

preprint2022arXiv

baymedr: An R Package and Web Application for the Calculation of Bayes Factors for Superiority, Equivalence, and Non-Inferiority Designs

Clinical trials often seek to determine the superiority, equivalence, or non-inferiority of an experimental condition (e.g., a new drug) compared to a control condition (e.g., a placebo or an already existing drug). The use of frequentist statistical methods to analyze data for these types of designs is ubiquitous even though they have several limitations. Bayesian inference remedies many of these shortcomings and allows for intuitive interpretations. In this article, we outline the frequentist conceptualization of superiority, equivalence, and non-inferiority designs and discuss its disadvantages. Subsequently, we explain how Bayes factors can be used to compare the relative plausibility of competing hypotheses. We present baymedr, an R package and web application, that provides user-friendly tools for the computation of Bayes factors for superiority, equivalence, and non-inferiority designs. Instructions on how to use baymedr are provided and an example illustrates how already existing results can be reanalyzed with baymedr.